64Cu-PSMA-BCH: a new radiotracer for delayed PET imaging of prostate cancer

被引：0
|
作者：
Teli Liu
Chen Liu
Zhongyi Zhang
Ning Zhang
Xiaoyi Guo
Lei Xia
Jinquan Jiang
Qing Xie
Kun Yan
Steven P. Rowe
Hua Zhu
Zhi Yang
机构：
[1] Peking University Cancer Hospital & Institute,Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education/Beijing), NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), D
[2] Peking University Cancer Hospital & Institute,Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Ultrasonography
[3] Peking University Cancer Hospital & Institute,Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Urology
[4] Johns Hopkins University School of Medicine,The James Buchanan Brady Urology Institute and Department of Urology, and The Russell H. Morgan, Department of Radiology and Radiological Science
来源：
European Journal of Nuclear Medicine and Molecular Imaging | 2021年 / 48卷
关键词：
Cu-PSMA; Prostate cancer; PET/CT; Delayed imaging; Targeted biopsies;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4508 / 4516
页数：8
相关论文
共 50 条
  • [21] PSMA PET imaging in the diagnosis and management of prostate cancer
    Sina Houshmand
    Courtney Lawhn-Heath
    Spencer Behr
    Abdominal Radiology, 2023, 48 : 3610 - 3623
  • [22] PROSTATE CANCER 18F-fluciclovine PET or PSMA PET for prostate cancer imaging?
    Turkbey, Baris
    Choyke, Peter L.
    NATURE REVIEWS UROLOGY, 2020, 17 (01) : 9 - 10
  • [23] 64Cu-PSMA-617 PET/CT Imaging of Prostate Adenocarcinoma: First In-Human Studies
    Grubmueller, Bernhard
    Baum, Richard P.
    Capasso, Enza
    Singh, Aviral
    Ahmadi, Yasaman
    Knoll, Peter
    Floth, Andreas
    Righi, Sergio
    Zandieh, Shahin
    Meleddu, Carlo
    Shariat, Shahrokh F.
    Klingler, Hans Christoph
    Mirzaei, Siroos
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2016, 31 (08) : 277 - 286
  • [24] Preclinical Evaluation and Pilot Clinical Study of Al18F-PSMA-BCH for Prostate Cancer PET Imaging
    Liu, Teli
    Liu, Chen
    Xu, Xiaoxia
    Liu, Fei
    Guo, Xiaoyi
    Li, Nan
    Wang, Xuejuan
    Yang, Jianhua
    Yang, Xing
    Zhu, Hua
    Yang, Zhi
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (09) : 1284 - 1292
  • [25] Preclinical evaluation of a 64Cu-labeled disintegrin for PET imaging of prostate cancer
    Hossein Jadvar
    Kai Chen
    Ryan Park
    Li-Peng Yap
    Ivetta Vorobyova
    Steve Swenson
    Francis S. Markland
    Amino Acids, 2019, 51 : 1569 - 1575
  • [26] Preclinical evaluation of a 64Cu-labeled disintegrin for PET imaging of prostate cancer
    Jadvar, Hossein
    Chen, Kai
    Park, Ryan
    Yap, Li-Peng
    Vorobyova, Ivetta
    Swenson, Steve
    Markland, Francis S.
    AMINO ACIDS, 2019, 51 (10-12) : 1569 - 1575
  • [27] 64Cu-labeled inhibitors of prostate specific membrane antigen for PET imaging of prostate cancer
    Banerjee, Sangeeta R.
    Pullambhatla, Mrudula
    Byun, Youngjoo
    Foss, Catherine
    Nimmagadda, Sridhar
    Ferdani, Riccardo
    Anderson, Carolyn J.
    Mease, Ronnie C.
    Pomper, Martin G.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2011, 54 : S369 - S369
  • [28] [64Cu]Cu-PSMA-Q PET/CT in late stage Prostate Cancer: a Diagnostic and Dosimetric Study
    Li, S.
    Zhang, H.
    Chen, F.
    Li, Z.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S551 - S551
  • [29] Synthesis and preclinical evaluation of 68Ga-PSMA-BCH for prostate cancer imaging
    Liu, Teli
    Liu, Chen
    Liu, Fei
    Xu, Xiaoxia
    Guo, Xiaoyi
    Xia, Lei
    Zhu, Hua
    Yang, Zhi
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (07) : 933 - 937
  • [30] Will 68Ga-PSMA PET become the New Imaging Standard for Prostate Cancer?
    Duewel, C.
    Eiber, M.
    Maurer, T.
    AKTUELLE UROLOGIE, 2016, 47 (05) : 378 - 382
12345